Ovarian Stimulation Outcomes During a GnRH Antagonist Protocol for In-vitro Fertilization When Comparing Trigger Day Decision by Physicians Versus an Artificial Intelligence-based Algorithm.

ConditionIVF Outcomes

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-45

SponsorFertilAI

About this trial

To compare the number of mature oocytes following a GnRH antagonist in-vitro fertilization stimulation cycle when comparing trigger day timing decision by physicians versus an artificial intelligence-based algorithm

Eligibility criteria

Qualifiers

All patients undergoing an ovarian stimulation cycle utilizing the GnRH antagonist protocol for oocyte cryopreservation or for fertilization via intracytoplasmic sperm injection (ICSI) (any treatment where oocytes are denuded and maturity may be assessed).

Disqualifiers

Loss to follow-up, patient retracts consent to participate

Trial design

Treatments tested in this trial

Artificial intelligence-based algorithm

Treatment groups

180 Participants

are divided into 2 treatment groups

Sponsors and collaborators

FertilAI

Lead sponsor

Source ClinicalTrials.gov